» Articles » PMID: 34269964

Latent Tri-lineage Potential of Human Menstrual Blood-Derived Mesenchymal Stromal Cells Revealed by Specific In Vitro Culture Conditions

Overview
Journal Mol Neurobiol
Date 2021 Jul 16
PMID 34269964
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Human menstrual blood-derived mesenchymal stromal cells (MenSCs) have become not only an important source of stromal cells for cell therapy but also a cellular source for neurologic disorders in vitro modeling. By using culture protocols originally developed in our laboratory, we show that MenSCs can be converted into floating neurospheres (NSs) using the Fast-N-Spheres medium for 24-72 h and can be transdifferentiated into functional dopaminergic-like (DALNs, ~ 26% TH + /DAT + flow cytometry) and cholinergic-like neurons (ChLNs, ~ 46% ChAT + /VAChT flow cytometry) which responded to dopamine- and acetylcholine-triggered neuronal Ca inward stimuli when cultured with the NeuroForsk and the Cholinergic-N-Run medium, respectively in a timely fashion (i.e., 4-7 days). Here, we also report a direct transdifferentiation method to induce MenSCs into functional astrocyte-like cells (ALCs) by incubation of MenSCs in commercial Gibco® Astrocyte medium in 7 days. The MSC-derived ALCs (~ 59% GFAP + /S100β +) were found to respond to glutamate-induced Ca inward stimuli. Altogether, these results show that MenSCs are a reliable source to obtain functional neurogenic cells to further investigate the neurobiology of neurologic disorders.

Citing Articles

Combination of Tramiprosate, Curcumin, and SP600125 Reduces the Neuropathological Phenotype in Familial Alzheimer Disease PSEN1 I416T Cholinergic-like Neurons.

Gomez-Sequeda N, Jimenez-Del-Rio M, Velez-Pardo C Int J Mol Sci. 2024; 25(9).

PMID: 38732141 PMC: 11084854. DOI: 10.3390/ijms25094925.


High Yield of Functional Dopamine-like Neurons Obtained in NeuroForsk 2.0 Medium to Study Acute and Chronic Rotenone Effects on Oxidative Stress, Autophagy, and Apoptosis.

Quintero-Espinosa D, Velez-Pardo C, Jimenez-Del-Rio M Int J Mol Sci. 2023; 24(21).

PMID: 37958728 PMC: 10647258. DOI: 10.3390/ijms242115744.


Cholinergic-like neurons and cerebral spheroids bearing the PSEN1 p.Ile416Thr variant mirror Alzheimer's disease neuropathology.

Gomez-Sequeda N, Mendivil-Perez M, Jimenez-Del-Rio M, Lopera F, Velez-Pardo C Sci Rep. 2023; 13(1):12833.

PMID: 37553376 PMC: 10409854. DOI: 10.1038/s41598-023-39630-4.


Body fluid-derived stem cells - an untapped stem cell source in genitourinary regeneration.

Huang R, Li Q, Ma J, Atala A, Zhang Y Nat Rev Urol. 2023; 20(12):739-761.

PMID: 37414959 PMC: 11639537. DOI: 10.1038/s41585-023-00787-2.


PSEN1 E280A Cholinergic-like Neurons and Cerebral Spheroids Derived from Mesenchymal Stromal Cells and from Induced Pluripotent Stem Cells Are Neuropathologically Equivalent.

Mendivil-Perez M, Velez-Pardo C, Lopera F, Kosik K, Jimenez-Del-Rio M Int J Mol Sci. 2023; 24(10).

PMID: 37240306 PMC: 10218810. DOI: 10.3390/ijms24108957.


References
1.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View

2.
Viswanathan S, Shi Y, Galipeau J, Krampera M, LeBlanc K, Martin I . Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy. 2019; 21(10):1019-1024. DOI: 10.1016/j.jcyt.2019.08.002. View

3.
Staff N, Jones D, Singer W . Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases. Mayo Clin Proc. 2019; 94(5):892-905. PMC: 6643282. DOI: 10.1016/j.mayocp.2019.01.001. View

4.
Choudhary P, Gupta A, Singh S . Therapeutic Advancement in Neuronal Transdifferentiation of Mesenchymal Stromal Cells for Neurological Disorders. J Mol Neurosci. 2020; 71(5):889-901. DOI: 10.1007/s12031-020-01714-5. View

5.
Shariati A, Nemati R, Sadeghipour Y, Yaghoubi Y, Baghbani R, Javidi K . Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier. Eur J Cell Biol. 2020; 99(6):151097. DOI: 10.1016/j.ejcb.2020.151097. View